Medical Protocols Exposed

During the pandemic, the introduction of "just in case" drugs raised serious concerns about their impact on patient outcomes, leading to accusations that many deaths were a result of misguided policies rather than the virus itself. The discussion highlights the troubling connections between politicians and pharmaceutical companies, revealing potential conflicts of interest that may have influenced critical health decisions. The alarming narrative questions the integrity of the systems in place and the accountability of those involved.